Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001936799-26-000003

Options or other derivatives

  • Chief Medical Officer acquired 66,440 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Sumner Michael John Chief Medical Officer 2026-03-04 Grant or award · Common Stock Option +36,832 36,832 D
Sumner Michael John Chief Medical Officer 2026-03-04 Grant or award · Restricted Stock Unit +29,608 29,608 D
Loading xslF345X05/wk-form4_1772747679.xml…